Induction of skewed Th1/Th2 T-cell differentiation via subcutaneous immunization with Freund's adjuvant

Experimental Dermatology

Volumn 11, Issue 2, 2002, Pages 126-134

  Shibaki, A ^a   Katz, Stephen I ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cytokine; Dendritic cells; Langerhans cells; T cells

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CYTOKINE; FREUND ADJUVANT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EMULSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNIZATION; LANGERHANS CELL; LYMPH NODE CELL; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CLASSIFICATION; CYTOLOGY; IMMUNOLOGY; LYMPH NODE; METABOLISM; METHODOLOGY; PHYSIOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DENDRITIC CELLS; FEMALE; FREUND'S ADJUVANT; IMMUNIZATION; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN-12; LYMPH NODES; MICE; MICE, INBRED BALB C; TH1 CELLS; TH2 CELLS;

EID: 0036551108     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0625.2002.110204.x     Document Type: Article

References (35)

1. Mosmann T R, Coffman R L. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989: 7: 145-173.
2. Abbas A K, Murphy K M, Sher A. Functional diversity of helper T lymphocytes. Nature 1996: 383: 787-793.
3. Freund J. The mode of action of immunologic adjuvants. Adv Tuberc Res 1956: 7: 130-148.
4. Warren H S, Vogel F R, Chedid L A. Current status of immunological adjuvants. Annu Rev Immunol 1986: 4: 369-388.
5. Gupta R K, Relyveld E H, Lindblad E B, Bizzini B, Ben-Efraim S, Gupta C K. Adjuvants - A balance between toxicity and adjuvanticity. Vaccine 1993: 11: 293-306.
6. Marusic S, Tonegawa S. Tolerance induction and autoimmune encephalomyelitis amelioration after administration of myelin basic protein-derived peptide. J Exp Med 1997: 186: 507-515.
7. Perez V L, Van Parijs L, Biuckians A, Zheng X X, Strom T B, Abbas A. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 1997: 6: 411-417.
8. Yip H C, Karulin A Y, Tary-Lehmann M et al. Adjuvant-guided type-1 and type-2 immunity: Infectious/noninfectious dichotomy defines the class of response. J Immunol 1999: 162: 3942-3949.
9. Wang L F, Lin J Y, Hsieh K H, Lin R H. Epicutaneous exposure of protein antigen induces a predominant Th2-like response with high IgE production in mice. J Immunol 1996: 156: 4077-4082.
10. Weiner H L. Oral tolerance: Immune mechanisms and treatment of autoimmune diseases. Immunol Today 1997: 18: 335-343.
11. Tian J, Atkinson M A, Clare-Salzler M et al. Nasal administration of glutamate decarboxylase (GAD65) peptides induced Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 1996: 183: 1561-1567.
12. Sulzberger M B. Arsphenamine hypersensitiveness in guinea pigs. II. Experiments demonstrating the role of the skin both as originator and as site of the hypersensitiveness. Arch Dermatol Syph 1930: 839.
13. Vremec D, Zorbas M, Scollay R et al. The surface phenotype of dendritic cells purified from mouse thymus and spleen: Investigation of the CD8 expression by a subpopulation of dendritic cells. J Exp Med 1992: 176: 47-58.
14. Jakob T, Walker P S, Krieg A M, Udey M C, Vogel J C. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: A role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J Immunol 1998: 161: 3042-3049.
15. Rissoan M C, Soumelis V, Kadowaki N et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999: 283: 1183-1186.
16. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med 1999: 189: 587-592.
17. Pulendran B, Smith JL, Caspary G et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci U S A 1999: 96: 1036-1041.
18. Anjuere F, Martin P, Ferrero I et al. Definition of dendritic cell subpopulations present in the spleen, Peyer's patches, lymph nodes, and skin of the mouse. Blood 1999: 93: 590-598.
19. Anjuere F, Martinez Del Hoyo G, Martin P, Ardavin C. Langerhans cells acquire a CD8+ dendritic cell phenotype on maturation by CD40 ligation. J Leukoc Biol 2000: 67: 206-209.
20. Randolph G J, Beaulieu S, Lebecque S, Steinman R M, Muller W A. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 1998: 282: 480-483.
21. Randolph G J, Inaba K, Robbiani D F, Steinman R M, Muller W A. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 1999: 11: 753-761.
22. Macatonia S E, Hosken N A, Litton M et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 1995: 154: 5071-5079.
23. Heufler C, Koch F, Stanzl U et al. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol 1996: 26: 659-668.
24. Stoll S, Jonuleit H, Schmitt E et al. Production of functional IL-18 by different subtypes of murine and human dentritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur J Immunol 1998: 28: 3231-3239.
25. De Saint-Vis B, Fugier-Vivier I, Massacrier C et al. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J Immunol 1998: 160: 1666-1676.
26. Kuchroo V K, Das M P, Brown J A et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 1995: 80: 707-718.
27. Ohshima Y, Tanaka Y, Tozawa H, Takahashi Y, Maliszewski C, Delespesse G. Expression and function of OX40 ligand on human dendritic cells. J Immunol 1997: 159: 3838-3848.
28. Flynn S, Toellner K M, Raykundalia C, Goodall M, Lane P. CD4 T cell cytokine differentiation: The B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1. J Exp Med 1998: 188: 297-304.
29. Vowels B R, Cassin M, Vonderheid E C, Rook AH. Aberrant cytokine production by Sezary syndrome patients: Cytokine secretion pattern resembles murine Th2 cells. J Invest Dermatol 1992: 99: 90-94.
30. Cooper K D. Atopic dermatitis: Recent trends in pathogenesis and therapy. J Invest Dermatol 1994: 102: 128-137.
31. Kapsenberg M L, Wierenga E A, Stiekema F E, Tiggelman A M, Bos J D. Th1 lymphokine production profiles of nickel-specific CD4+ T-lymphocyte clones from nickel contact allergic and non-allergic individuals. J Invest Dermatol 1992: 98: 59-63.
32. Schlaak J F, Buslau M, Jochum W et al. T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 1994: 102: 145-149.
33. Vollmer S, Menssen A, Trommler P, Schendel D, Prinz J C. T lympchocytes derived from skin lesiosn of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells. Eur J Immunol 1994: 24: 2377-2382.
34. Jang I G, Yang J K, Lee H J et al. Clinical improvement and immunohistochemical findings in severe atopic dermtitis treated with interferon gamma. J Am Acad Dermatol 2000: 42: 1033-1040.
35. Asadullah K, Docke W D, Ebeling M et al. Interleukin 10 treatment of psoriasis: Clinical results of a phase 2 trial. Arch Dermatol 1999: 135: 187-192.